Annals of Ophthalmology

, Volume 37, Issue 4, pp 235–236 | Cite as

Mucopolysaccharidosis type I therapy

  • Fernando H. Murillo-Lopez
Consultation Section


  1. Cleary MA, Wraith JE. The presenting features of mucopolysaccharidosis type IH (Hurler syndrome). Acta Paediatr 1995;84:337–339.PubMedGoogle Scholar
  2. Francois J. Ocular manifestations of the mucopolysaccharidoses. Ophthalmologica 1974;169:345–361PubMedCrossRefGoogle Scholar
  3. Grewal SS, Wynn R, Abdenur JE, et al. Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome. Genet Med 2005;7:143–146.PubMedCrossRefGoogle Scholar
  4. Wraith JE. The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother 2005;6:489–506.PubMedCrossRefGoogle Scholar

Copyright information

© ASCO 2005

Authors and Affiliations

  • Fernando H. Murillo-Lopez
    • 1
  1. 1.La PazBolivia

Personalised recommendations